Rie Yanagisawa Selected Research

Disseminated Intravascular Coagulation

7/2009	Urinary trypsin inhibitor protects against liver injury and coagulation pathway dysregulation induced by lipopolysaccharide/D-galactosamine in mice.
1/2009	Protective role of urinary trypsin inhibitor in lung expression of proinflammatory cytokines accompanied by lethal liver injury in mice.
11/2008	Protective effects of urinary trypsin inhibitor on systemic inflammatory response induced by lipopolysaccharide.
4/2005	Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide.
3/2005	Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rie Yanagisawa Research Topics

Disease

50	Inflammation (Inflammations) 12/2021 - 01/2002
28	Pneumonia (Pneumonitis) 10/2021 - 05/2002
19	Asthma (Bronchial Asthma) 01/2022 - 01/2002
11	Acute Lung Injury 11/2008 - 12/2002
9	Atopic Dermatitis (Atopic Eczema) 12/2021 - 08/2006
8	Lung Injury 04/2011 - 04/2002
5	Body Weight (Weight, Body) 01/2019 - 04/2004
5	Disseminated Intravascular Coagulation 07/2009 - 03/2005
5	Shock 07/2009 - 03/2005
5	Pancreatitis 07/2009 - 03/2005
4	Obesity 01/2019 - 04/2007
4	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2014 - 04/2002
4	Hemorrhage 01/2013 - 05/2002
4	Arthritis (Polyarthritis) 01/2007 - 08/2003
3	Hypersensitivity (Allergy) 04/2010 - 11/2005
3	Infections 03/2007 - 10/2004
3	Lung Diseases (Lung Disease) 11/2006 - 04/2003
3	Pulmonary Edema 09/2006 - 12/2002
2	Respiratory Hypersensitivity 01/2019 - 08/2007
2	Skin Diseases (Skin Disease) 02/2014 - 03/2009
2	Colitis 05/2013 - 08/2004
2	Eosinophilia 10/2010 - 08/2010
2	Hyperplasia 04/2010 - 08/2007
2	Diabetes Mellitus 04/2007 - 01/2007
2	Rheumatoid Arthritis 07/2004 - 07/2003
2	Edema (Dropsy) 04/2003 - 05/2002
1	Necrosis 01/2022
1	Anemia 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Hyperglycemia 01/2019
1	Type 2 Diabetes Mellitus (MODY) 08/2014

Drug/Important Bio-Agent (IBA)

29	CytokinesIBA 01/2019 - 01/2002
22	Vehicle Emissions (Emissions, Vehicle)IBA 06/2014 - 04/2002
22	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2013 - 04/2002
22	LipopolysaccharidesIBA 01/2009 - 12/2002
18	AllergensIBA 01/2022 - 01/2002
13	ChemokinesIBA 01/2019 - 05/2002
12	EndotoxinsIBA 09/2007 - 05/2002
10	AntigensIBA 02/2009 - 08/2003
8	Immunoglobulin G (IgG)IBA 01/2019 - 01/2002
8	Particulate MatterIBA 06/2014 - 09/2006
7	Interleukin-6 (Interleukin 6)IBA 01/2017 - 06/2004
7	Immunoglobulins (Immunoglobulin)IBA 02/2014 - 07/2002
6	SandIBA 01/2012 - 11/2005
6	Proteins (Proteins, Gene)FDA Link 04/2010 - 01/2004
6	urinastatin (MR 20)IBA 07/2009 - 03/2005
5	Interleukin-5 (Interleukin 5)IBA 11/2020 - 01/2002
5	phthalic acid (phthalate)IBA 02/2014 - 08/2006
5	Organic Chemicals (Chemicals, Organic)IBA 01/2013 - 11/2004
5	Chemotactic FactorsIBA 12/2012 - 04/2004
5	OvalbuminIBA 06/2012 - 07/2002
5	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 07/2009 - 03/2005
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 10/2019 - 04/2002
4	Immunoglobulin E (IgE)IBA 01/2019 - 01/2002
4	Pharmaceutical PreparationsIBA 01/2017 - 03/2005
4	Diethylhexyl Phthalate (DEHP)IBA 02/2014 - 08/2006
4	MetallothioneinIBA 05/2013 - 01/2005
4	InterleukinsIBA 01/2007 - 06/2004
4	Rosmarinic AcidIBA 07/2006 - 04/2003
3	SootIBA 04/2011 - 09/2006
3	Carbon Nanotubes (Carbon Nanotube)IBA 04/2010 - 12/2008
3	Interleukin-1beta (Interleukin 1 beta)IBA 03/2010 - 01/2004
3	AntioxidantsIBA 10/2009 - 12/2002
3	CarbonIBA 12/2008 - 09/2006
3	Vitamin E FDA LinkGeneric 10/2004 - 12/2002
2	Benzo(a)pyreneIBA 12/2021 - 11/2016
2	tris(1,3-dichloroisopropyl) phosphateIBA 10/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 04/2004
2	bisphenol AIBA 01/2019 - 01/2018
2	Drinking WaterIBA 01/2019 - 08/2004
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2014
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 07/2005
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 12/2002
2	PlasticizersIBA 08/2014 - 05/2009
2	LipidsIBA 03/2014 - 12/2012
2	diisononyl phthalateIBA 02/2014 - 04/2010
2	PeroxiredoxinsIBA 12/2012 - 10/2009
2	OzoneIBA 12/2012 - 12/2008
2	InflammasomesIBA 01/2012 - 10/2010
2	Pancreatic Elastase (Elastase)IBA 04/2011 - 03/2010
2	beta-GlucansIBA 07/2009 - 09/2007
2	Leukocyte Elastase (Neutrophil Elastase)IBA 11/2008 - 03/2005
2	Interleukin-13IBA 08/2007 - 08/2005
2	RolipramIBA 01/2007 - 07/2004
2	Hemostatics (Antihemorrhagics)IBA 06/2006 - 06/2004
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2005 - 05/2002
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Heme Oxygenase-1IBA 01/2022
1	Flame Retardants (Fire Retardants)IBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	IronIBA 01/2021
1	Chemokine CCL11IBA 11/2020
1	Estrogen Receptor alphaIBA 11/2020
1	A-factor (Streptomyces)IBA 01/2019
1	decabromobiphenyl ether (decabromodiphenyl ether)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019